← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $466K of Karuna Therapeutics, Inc.

Sold$466,350
$93.27Price
5,000Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Fri, Jun 12. Filed Mon, Jun 15, 5:19 PM ET, after the close. Not investment advice.